Free Trial

Cresco Labs (CRLBF) Expected to Announce Quarterly Earnings on Friday

Cresco Labs logo with Medical background

Cresco Labs (OTCMKTS:CRLBF - Get Free Report) will likely be posting its quarterly earnings results before the market opens on Friday, May 9th. Analysts expect Cresco Labs to post earnings of ($0.03) per share and revenue of $165.48 million for the quarter.

Cresco Labs (OTCMKTS:CRLBF - Get Free Report) last announced its earnings results on Friday, March 14th. The company reported ($0.01) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.01). Cresco Labs had a negative return on equity of 16.52% and a negative net margin of 9.15%. The company had revenue of $176.00 million during the quarter, compared to analyst estimates of $172.10 million. On average, analysts expect Cresco Labs to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Cresco Labs Stock Down 6.8 %

Shares of OTCMKTS:CRLBF opened at $0.91 on Friday. Cresco Labs has a 12 month low of $0.52 and a 12 month high of $2.35. The firm has a market cap of $446.29 million, a P/E ratio of -4.54 and a beta of 1.81. The company has a quick ratio of 1.39, a current ratio of 1.97 and a debt-to-equity ratio of 1.80. The company's 50-day moving average price is $0.72 and its two-hundred day moving average price is $0.97.

Wall Street Analyst Weigh In

Separately, Cormark upgraded Cresco Labs from a "hold" rating to a "moderate buy" rating in a research report on Monday, March 17th. Two equities research analysts have rated the stock with a hold rating, one has issued a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, Cresco Labs has an average rating of "Buy" and a consensus price target of $3.00.

Check Out Our Latest Report on CRLBF

About Cresco Labs

(Get Free Report)

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.

Featured Stories

Earnings History for Cresco Labs (OTCMKTS:CRLBF)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cresco Labs Right Now?

Before you consider Cresco Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cresco Labs wasn't on the list.

While Cresco Labs currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in May 2025
3 Stocks Offering Rare Generational Buying Opportunities
Make Your Money Work Harder: The Power of Dividend Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines